Vancomycin-associated DRESS demonstrates delay in AST abnormalities.
Drug reaction
Drug reaction with eosinophilia and systemic symptoms
Drug triggers
Inpatient dermatology
Laboratory values
Vancomycin
Journal
Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462
Informations de publication
Date de publication:
01 Nov 2024
01 Nov 2024
Historique:
received:
11
09
2024
accepted:
17
10
2024
revised:
11
10
2024
medline:
1
11
2024
pubmed:
1
11
2024
entrez:
1
11
2024
Statut:
epublish
Résumé
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe cutaneous adverse drug eruption characterized by rash, fever, lymphadenopathy, hematologic abnormalities, and organ dysfunction. Identifying causative agents and monitoring disease course in DRESS syndrome is crucial to prevent end-organ damage. The temporal relationship between causative medications including vancomycin and laboratory abnormalities in DRESS has not been studied, limiting the utility of laboratory data in monitoring disease course. Our study aims to investigate associations between medication class and peak serum laboratory values using simple linear regression (absolute eosinophils, creatinine, alanine aminotransferase [ALT] and aspartate aminotransferase [AST]). We found a significant difference between timing of peak AST values among vancomycin-triggered DRESS compared to other trigger groups. These findings draw attention to the increased role of AST as a diagnostic and monitoring tool in DRESS.
Identifiants
pubmed: 39485591
doi: 10.1007/s00403-024-03481-4
pii: 10.1007/s00403-024-03481-4
doi:
Substances chimiques
Vancomycin
6Q205EH1VU
Aspartate Aminotransferases
EC 2.6.1.1
Alanine Transaminase
EC 2.6.1.2
Anti-Bacterial Agents
0
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
736Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Kardaun SH, Sekula P, Valeyrie-Allanore L et al (2013) Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169(5):1071–1080. https://doi.org/10.1111/bjd.12501
doi: 10.1111/bjd.12501
pubmed: 23855313
Madigan LM, Fox LP (2019) Vancomycin-associated drug-induced hypersensitivity syndrome. J Am Acad Dermatol 81(1):123–128. https://doi.org/10.1016/j.jaad.2019.02.002
doi: 10.1016/j.jaad.2019.02.002
pubmed: 30738120
Pannu AK, Saroch A (2017) Diagnostic criteria for drug rash and eosinophilia with systemic symptoms. J Family Med Prim Care 6(3):693–694. https://doi.org/10.4103/2249-4863.222050
doi: 10.4103/2249-4863.222050
pubmed: 29417040
pmcid: 5787987
Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S (2021) Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol 77(3):275–289. https://doi.org/10.1007/s00228-020-03005-9
doi: 10.1007/s00228-020-03005-9
pubmed: 33025080
Sim DW, Yu JE, Jeong J et al (2019) Variation of clinical manifestations according to culprit drugs in DRESS syndrome. Pharmacoepidemiol Drug Saf 28(6):840–848. https://doi.org/10.1002/pds.4774
doi: 10.1002/pds.4774
pubmed: 31044478